Syneron Medical to Report Third Quarter 2012 Financial Results on November 7, 2012
29 Octubre 2012 - 6:00AM
Syneron Medical Ltd. (Nasdaq:ELOS), the leading global aesthetic
device company, today announced that it will release third quarter
2012 financial results before the market opens on Wednesday,
November 7, 2012. The earnings release will be available on
Syneron's website at www.investors.syneron.com.
Syneron management will host a conference call and a live
webcast at 8:30 a.m. (ET) on the same day. A question & answer
session will follow management's discussion of events in the third
quarter 2012.
Investors and analysts may participate in the conference call
using the following dial-in numbers:
US (toll free): (877) 844-6886 International: (970) 315-0315
The conference passcode for both is 47521925.
Investors and other interested parties can also access a live
webcast of the conference call through the Investor Relations page
on Syneron's website at www.investors.syneron.com. Please log-in at
least 10 minutes prior to the conference call in order to download
the applicable audio software. Following the conclusion of the
call, a replay of the webcast will be available within 24 hours on
the Company's website.
About Syneron Medical Ltd.
Syneron Medical Ltd. (Nasdaq:ELOS) is the leading global
aesthetic device company with a comprehensive product portfolio and
a global distribution footprint. The Company's technology enables
physicians to provide advanced solutions for a broad range of
medical-aesthetic applications including body contouring, hair
removal, wrinkle reduction, rejuvenation of the skin's appearance
through the treatment of superficial benign vascular and pigmented
lesions, and the treatment of acne, leg veins and cellulite. The
Company sells its products under two distinct brands, Syneron and
Candela. Founded in 2000, the corporate, R&D, and manufacturing
headquarters for Syneron Medical Ltd. are located in Israel.
Syneron also has R&D and manufacturing operations in the US.
The Company markets and services and supports its products in 90
countries. It has offices in North America, France, Germany, Italy,
Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and
distributors worldwide.
CONTACT: David Schlachet, Chief Financial
Officer, Syneron Medical
Email: david.schlachet@syneron.com
Zack Kubow, The Ruth Group
646-536-7020
Email: zkubow@theruthgroup.com
Syneron Medical Ltd. - Ordinary Shares (NASDAQ:ELOS)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Syneron Medical Ltd. - Ordinary Shares (NASDAQ:ELOS)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024